Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Credit agrmnt [a] Appointed director Quarterly results Director departure
|
ANGIOTECH PHARMACEUTICALS INC (ANPMF)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/17/2011 |
4/A
| Neske Tammy (SVP, Human Resources) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Disposed of 3,000 shares
@ $0 Disposed of 3,300 shares
@ $0 Disposed of 5,500 shares
@ $0 Disposed of 85,000 options to buy
@ $0 Disposed of 150,000 options to buy
@ $0 Disposed of 50,000 options to buy
@ $0 |
|
05/17/2011 |
4/A
| Gross Jeffrey M (SVP, Research & Development) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Disposed of 9,000 shares
@ $0 Disposed of 6,000 shares
@ $0 Disposed of 1,500 shares
@ $0 Disposed of 2,000 shares
@ $0 Disposed of 20,000 shares
@ $0 Disposed of 12,500 shares
@ $0 Disposed of 85,000 options to buy
@ $0 Disposed of 150,000 options to buy
@ $0 Disposed of 100,000 options to buy
@ $0 Disposed of 25,000 options to buy
@ $0 |
|
05/17/2011 |
4/A
| Diaz Victor Manuel (SVP, Global Manufacturing) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Disposed of 85,000 options to buy
@ $1.05, valued at
$89.3k
Disposed of 150,000 options to buy
@ $0.27, valued at
$40.5k
Disposed of 150,000 options to buy
@ $0.16, valued at
$24k
Disposed of 30,000 options to buy
@ $5.69, valued at
$170.7k
|
|
05/17/2011 |
4/A
| Bryant Steven R. (SVP, Specialty Medical Device) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Disposed of 19,261 options to buy
@ $15.44, valued at
$297.4k
Disposed of 15,000 options to buy
@ $7.65, valued at
$114.8k
Disposed of 25,000 options to buy
@ $0.26, valued at
$6.5k
Disposed of 22,000 options to buy
@ $0.27, valued at
$5.9k
Disposed of 50,000 options to buy
@ $1.05, valued at
$52.5k
|
|
05/17/2011 |
4/A
| Cunliffe Sean (SVP, Sales & Marketing) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Disposed of 70,700 shares
@ $0 Disposed of 85,000 options to buy
@ $1.05, valued at
$89.3k
Disposed of 100,000 options to buy
@ $1.28, valued at
$128k
|
|
05/17/2011 |
4/A
| Dent Jay Bernard (SVP, Finance) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Disposed of 6,000 shares
@ $0 Disposed of 8,000 shares
@ $0 Disposed of 2,700 shares
@ $0 Disposed of 35,000 options to buy
@ $0 Disposed of 75,000 options to buy
@ $0 Disposed of 70,000 options to buy
@ $0 Disposed of 65,000 options to buy
@ $0 |
|
05/17/2011 |
4/A
| Bailey K Thomas (CFO) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Disposed of 15,000 shares
@ $0 Disposed of 1,100 shares
@ $0 Disposed of 13,900 shares
@ $0 Disposed of 160,000 options to buy
@ $1.05, valued at
$168k
Disposed of 250,000 options to buy
@ $0.27, valued at
$67.5k
Disposed of 250,000 options to buy
@ $0.16, valued at
$40k
Disposed of 200,000 options to buy
@ $7.65, valued at
$1.5M
|
|
05/17/2011 |
4/A
| McMasters David (SVP, Legal) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Disposed of 2,000 shares
@ $0 Disposed of 800 shares
@ $0 Disposed of 135,000 options to buy
@ $1.05, valued at
$141.8k
Disposed of 200,000 options to buy
@ $0.27, valued at
$54k
Disposed of 200,000 options to buy
@ $0.16, valued at
$32k
Disposed of 50,000 options to buy
@ $13.468, valued at
$673.4k
Disposed of 175,000 options to buy
@ $7.65, valued at
$1.3M
|
|
05/17/2011 |
4/A
| Hunter William L (CEO & President) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Disposed of 435,356 shares
@ $0 Disposed of 375,000 shares
@ $0 Disposed of 102,000 shares
@ $0 Disposed of 3,332,616 shares
@ $0 Disposed of 567,595 shares
@ $0 Disposed of 156,933 shares
@ $0 Disposed of 33,000 shares
@ $0 Disposed of 89,692 shares
@ $0 Disposed of 40,848 shares
@ $0 Disposed of 53,000 shares
@ $0 Disposed of 30,500 shares
@ $0 |
|
03/30/2010 |
4/A
| Willms Arthur H (Director) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC
Txns:
| Granted 12,500 options to buy
@ $0 |
|
08/31/2009 |
4/A
| Form 4 - Statement of changes in beneficial ownership of securities [amend] |
07/07/2009 |
4/A
| Richardson Hartley T (Former Director/Consultant) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC |
12/15/2008 |
4/A
| HOWARD DAVID T (Director) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC |
12/15/2008 |
4/A
| Neske Tammy (Senior VP, Human Resources) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC |
12/15/2008 |
4/A
| MCKINNELL HENRY A (Director) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC |
12/15/2008 |
4/A
| Diaz Victor Manuel (Senior VP, Manufacturing) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC |
12/15/2008 |
4/A
| Chen Jonathan W (Senior VP, Financial Strategy) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC |
12/15/2008 |
4/A
| Brown Edward M (Director) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC |
12/15/2008 |
4/A
| Bailey K Thomas (CFO) has filed a Form 4 on ANGIOTECH PHARMACEUTICALS INC |
|
|